M. Thacker

Antiviral management of Influenza A (H1N1) in critical care.

R. Shulman, M. Borthwick, I. Kidd, 2011 .

Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome - clinical guidelines.

C. Ball, Dominic Walsh, M. Thacker, 2008, Nursing in critical care.

Voriconazole in the treatment of invasive fungal infections.

S. Keady, M. Thacker, 2005, Intensive & Critical Care Nursing.

Rasburicase in the prevention and treatment of tumour lysis syndrome.

S. Keady, M. Thacker, N. Mayne, 2008, Intensive & critical care nursing.

Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.

Mayur R Gamit, J. Canny, M. Beadsworth, 2022, The Lancet. Infectious diseases.

Developing a process for credentialing advanced level practice in the pharmacy profession using a multi-source evaluation tool.

I. Bates, R. Shulman, D. Mcrobbie, 2011 .

Impact of the introduction of a specialist critical care pharmacist on the level of pharmaceutical care provided to the critical care unit

I. Bates, Y. Jani, R. Shulman, 2016, The International journal of pharmacy practice.

Caspofungin in the treatment of invasive fungal infections.

S. Keady, M. Thacker, 2006, Intensive & critical care nursing.